Related Experiment Video
Updated: Mar 25, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in
M Monaghan1, H Wakabayashi1, A E Griffiths1,2
1Department of Biochemistry and Biophysics, University of Rochester School of Medicine, Rochester, NY, USA.
Factor VIIIa (FVIIIa) stability is enhanced by specific interactions at the A2-A3 interface. Creating a disulfide linkage between D666 and S1788 significantly boosts FVIIIa stability, reducing decay rates.
Area of Science:
- Biochemistry
- Molecular Biology
- Protein Stability
Background:
- Factor VIIIa (FVIIIa) activity and stability depend on the A2 subunit's association with the A1/A3C1C2 dimer.
- Interactions stabilizing this association are not fully understood.
- Previous mutations (D666A, Y1792F) increased FVIIIa decay, indicating residue importance.
Purpose of the Study:
- To identify specific interactions involving residues D666 and Y1792 at the FVIIIa A2-A3 interface.
- To elucidate the role of these interactions in FVIIIa stability and function.
Main Methods:
- Site-directed mutagenesis of FVIIIa residues D666 and Y1792.
- Biochemical analysis of FVIII variant stability and activity.
- Introduction of disulfide bonds via cysteine mutations (D666C/S1788C).
Main Results:
- Identified stabilizing hydrogen bonds between D666-S1788 and T657-Y1792.
- Swap variants (D666S/S1787D, T657Y/Y1792T) showed wild-type stability.
- Single mutations (D666S, S1787D, Y1792T) increased FVIIIa decay; T657Y reduced activity.
- A D666C/S1788C variant with a disulfide linkage exhibited a decay rate 1% of wild-type.
Conclusions:
- Specific hydrogen bonds (D666-S1787, T657-Y1792) are crucial for FVIIIa stability.
- Disulfide bond formation across the A2-A3 interface dramatically enhances FVIIIa stability.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Intracellular Signaling Affects Focal Adhesions
Some...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation

